Donated eggs and embryos will form the basis of creation of human stem cells. These cells will be sold to stem research outfits and researchers. The pricing will be extremely soft, dictated by a non-profit motive. The center will be a hotbed for testing drugs and evolving new medicines, to find answers for chronic diseases like diabetes and leukemia.
Neil Francis, deputy chief executive of Scottish Enterprise Edinburgh and Lothian, said, "As well as having huge potential to make significant breakthroughs in the treatment of some of the most debilitating diseases, the stem cell sector has the potential to become one of the key drivers of Scotland's knowledge economy."